MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

Search

Moleculin Biotech Inc

Geschlossen

0.46

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

0.45

Max

0.48

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+1319.15% upside

Moleculin Biotech Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

13. Okt. 2025, 21:45 UTC

Akquisitionen, Fusionen, Übernahmen

Goldman Sachs to Acquire Industry Ventures for Up to $965 Million -- Update

13. Okt. 2025, 21:07 UTC

Akquisitionen, Fusionen, Übernahmen

Goldman Sachs to Acquire Industry Ventures for Up to $965 Million

13. Okt. 2025, 17:03 UTC

Wichtige Markttreiber

Canaan ADRs Climb on Launch of Gas-to-Computing Pilot in Canada

13. Okt. 2025, 23:53 UTC

Market Talk

Gold Rises, Buoyed by Bullish Fundamental Backdrop -- Market Talk

13. Okt. 2025, 23:39 UTC

Market Talk

Nikkei May Rise, Tracking Wall Street's Gains -- Market Talk

13. Okt. 2025, 22:15 UTC

Market Talk

Global Equities Roundup: Market Talk

13. Okt. 2025, 22:15 UTC

Market Talk

Precinct Properties NZ's Equity Raising Looks Opportunistic -- Market Talk

13. Okt. 2025, 21:57 UTC

Akquisitionen, Fusionen, Übernahmen

Goldman Buys $7B Venture-Capital Firm in Latest Asset-Management Bet -- Barrons.com

13. Okt. 2025, 21:36 UTC

Market Talk

Global Equities Roundup: Market Talk

13. Okt. 2025, 21:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

13. Okt. 2025, 21:36 UTC

Market Talk

Fletcher's Near-Term Headwinds Don't Cloud Earnings Opportunity -- Market Talk

13. Okt. 2025, 21:30 UTC

Akquisitionen, Fusionen, Übernahmen

Goldman Sachs to Acquire Industry Ventures for Up to $965M -- Update

13. Okt. 2025, 21:06 UTC

Akquisitionen, Fusionen, Übernahmen

Goldman Buys $7B Venture-Capital Firm in Latest Asset-Management Bet -- Barrons.com

13. Okt. 2025, 20:52 UTC

Akquisitionen, Fusionen, Übernahmen

Goldman Sachs to Acquire Industry Ventures for Up to $965M

13. Okt. 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

13. Okt. 2025, 20:35 UTC

Akquisitionen, Fusionen, Übernahmen

Goldman Expects to Close Deal in 1Q

13. Okt. 2025, 20:34 UTC

Akquisitionen, Fusionen, Übernahmen

Industry Ventures Will Be Part of Goldman's External Manager Platform, External Investing Group

13. Okt. 2025, 20:33 UTC

Akquisitionen, Fusionen, Übernahmen

Industry Ventures Currently Manages $7B of Assets Under Supervision

13. Okt. 2025, 20:32 UTC

Akquisitionen, Fusionen, Übernahmen

Goldman Sachs: Deal to Include Up to $300M of Additional Contingent Consideration Based on Future Performance Through 2030

13. Okt. 2025, 20:31 UTC

Akquisitionen, Fusionen, Übernahmen

Goldman Sachs: Consideration to Include $665M Cash and Equity Payable at Closing

13. Okt. 2025, 20:29 UTC

Akquisitionen, Fusionen, Übernahmen

Goldman Sachs to Buy VC Firm Industry Ventures

13. Okt. 2025, 19:05 UTC

Market Talk

Oil Futures Pick Up on Easing U.S.-China Tension -- Market Talk

13. Okt. 2025, 18:59 UTC

Market Talk

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

13. Okt. 2025, 18:26 UTC

Market Talk

Precious Metals Close at New Record Highs -- Market Talk

13. Okt. 2025, 18:10 UTC

Market Talk

Global Equities Roundup: Market Talk

13. Okt. 2025, 18:10 UTC

Market Talk

Broadcom's OpenAI Deal Highlights AI Opportunity -- Market Talk

13. Okt. 2025, 17:05 UTC

Market Talk

Global Equities Roundup: Market Talk

13. Okt. 2025, 17:05 UTC

Market Talk

OpenAI Deal Offers Huge Upside to Broadcom's Earnings -- Market Talk

13. Okt. 2025, 16:03 UTC

Akquisitionen, Fusionen, Übernahmen

Umicore Completes Sale, Subsequent Lease-in of Permanent Gold Inventories

13. Okt. 2025, 15:35 UTC

Market Talk

Precious Metals Push Record Highs Further -- Market Talk

Peer-Vergleich

Kursveränderung

Moleculin Biotech Inc Prognose

Kursziel

By TipRanks

1319.15% Vorteil

12-Monats-Prognose

Durchschnitt 6.67 USD  1319.15%

Hoch 12 USD

Tief 4 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Moleculin Biotech Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

3 ratings

3

Buy

0

Halten

0

Sell

Finanzen

$

help-icon Live chat